MINISTRY OF CHEMICALS AND FERTILIZERS LAUNCHES SCHEMES TO PROMOTE DOMESTIC MANUFACTURING OF BULK DRUGS AND MEDICAL DEVICES

MINISTRY OF CHEMICALS AND FERTILIZERS LAUNCHES SCHEMES TO PROMOTE DOMESTIC  MANUFACTURING OF BULK DRUGS AND MEDICAL DEVICES 

Intended benefits: 

• Make India self-reliant and capable of catering to the global demand for the selected bulk drugs and medical devices. 
• Reduce import dependence by compensating for the manufacturing disability. 
• Significantly bring down the manufacturing cost of bulk drugs & medical devices. 

For Medical Devices 

• Scheme for Promotion of Medical Device Parks 
• Objective: Create world-class infrastructure facilities to make the Indian medical device industry a global leader. 
• 4 Medical Device Parks to be set up with maximum grant-in-aid of Rs 100 crore to each. 
• One-time grant-in-aid will be provided which will be 90% of the project cost in the case of North-East and hilly States and 70% in the case of other States. 
• Implementation: Through State Implementing Agency, a legal entity, set up by the concerned State Government. 
• Production Linked Incentive (PI-I) Scheme for Promoting Domestic Manufacturing of Medical Devices 
• Objective: Boost domestic manufacturing of medical devices in four target segments, like Cancer care / Radiotherapy medical devices, Radiology & Imaging medical devices, etc. 
• Financial incentives will be given for five years, to boost domestic manufacturing and attract large investments. 
• Eligibility: Companies registered in India with Net worth more than 18 crores. 
• Implementation: Through a Project Management Agency responsible for providing secretarial, managerial, and implementation support. 

For Bulk Drugs 

• Scheme for Promotion of Bulk Drug Parks 
• Objective: Promote setting up of bulk drug parks in the country for providing easy access to world-class Common Infrastructure Facilities. 
• Envisages creation of 3 bulk drug parks with a total outlay of Rs 3000 crore and Maximum grant-in-aid for one bulk drug park to Rs.1000 crore. 
• One-time grant-in-aid will be provided which will be 90% of the project cost in the case of North-East and hilly States and 70% in the case of other States. 
• Implementation: Through State Implementing Agency. 
• PLI Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ DIs/APIs in India 
• Objective: Attain self-reliance and reduce import dependence in critical KSMs/ Drug Intermediates (Dls)/Active Pharmaceutical Ingredients (APIs). 
• Financial incentives will be provided on sales of 41 identified products (around 53 APIs) for six years. 
• Implementation: Through Project Management Agency.